Julie Lotharius

Julie Lotharius

UNVERIFIED PROFILE

Are you Julie Lotharius?   Register this Author

Register author
Julie Lotharius

Julie Lotharius

Publications by authors named "Julie Lotharius"

Are you Julie Lotharius?   Register this Author

19Publications

264Reads

31Profile Views

In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium species.

Antimicrob Agents Chemother 2012 Feb 14;56(2):703-7. Epub 2011 Nov 14.

Swiss Tropical & Public Health Institute, CH-4002 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.05039-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264280PMC
February 2012

Challenges in antimalarial drug discovery.

Future Med Chem 2011 Sep;3(11):1401-12

Medicines for Malaria Venture, Route de Pré-Bois 20, PO Box 1826, 1215 Geneva 15, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/fmc.11.91DOI Listing
September 2011

HIF prolyl hydroxylase inhibition increases cell viability and potentiates dopamine release in dopaminergic cells.

J Neurochem 2010 Oct 19;115(1):209-19. Epub 2010 Aug 19.

Discovery Biology Research, H. Lundbeck A/S, Valby, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1471-4159.2010.06917.xDOI Listing
October 2010

Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels.

Brain Res 2007 Dec 21;1185:18-32. Epub 2007 Sep 21.

Department of Molecular Biology, H. Lundbeck A/S, Ottiliavej 9, 2500 Valby, Denmark.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000689930702214
Publisher Site
http://dx.doi.org/10.1016/j.brainres.2007.09.028DOI Listing
December 2007

Inflammation in Parkinson's disease: causative or epiphenomenal?

Subcell Biochem 2007 ;42:249-79

Department of Pharmacology and Pharmacotherapeutics, The Danish University of Pharmaceutical Sciences, Universitetsparken 2, 2100 Copenhagen, Denmark.

View Article

Download full-text PDF

Source
August 2007

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

Exp Neurol 2005 Jun;193(2):279-90

Department of Pharmacology, Danish University of Pharmaceutical Sciences, Jagtvej 160, 2200 Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.expneurol.2005.01.013DOI Listing
June 2005

Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons.

Neurobiol Dis 2003 Oct;14(1):43-51

Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, MO 63108, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0969-9961(03)00013-5DOI Listing
October 2003

[Free radicals and ailing proteins--the culprits behind Parkinson disease?].

Lakartidningen 2003 Apr;100(15):1324-6, 1329-30

Universitetssjukhuset, Lund.

View Article

Download full-text PDF

Source
April 2003

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.

Nat Rev Neurosci 2002 Dec;3(12):932-42

Section for Neuronal Survival, Wallenberg Neuroscience Center, Department of Physiological Sciences, Lund University, BMC A10, 221 84 Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrn983DOI Listing
December 2002

Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line.

J Biol Chem 2002 Oct 26;277(41):38884-94. Epub 2002 Jul 26.

Section for Neuronal Survival, Wallenberg Neuroscience Center, Lund University, Lund 221 84, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M205518200DOI Listing
October 2002

Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.

Hum Mol Genet 2002 Oct;11(20):2395-407

Section for Neuronal Survival, Wallenberg Neuroscience Center, Lund University, Lund, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/11.20.2395DOI Listing
October 2002